|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Naishadham D, Jemal A and
Ahmedin J: Cancer statistics, 2013. CA Cancer J Clin. 63:11–30.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Arnold M, Rutherford MJ, Bardot A, Ferlay
J, Andersson TM, Myklebust TÅ, Tervonen H, Thursfield V, Ransom D,
Shack L, et al: Progress in cancer survival, mortality, and
incidence in seven high-income countries 1995-2014 (ICBP
SURVMARK-2): A population-based study. Lancet Oncol. 20:1493–1505.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Coleman RL, Fleming GF, Brady MF, Swisher
EM, Steffensen KD, Friedlander M, Okamoto A, Moore KN, Efrat
Ben-Baruch N, Werner TL, et al: Veliparib with First-Line
Chemotherapy and as Maintenance Therapy in Ovarian Cancer. N Engl J
Med. 381:2403–2415. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hsing CH, Lin MC, Choi PC, Huang WC, Kai
JI, Tsai CC, Cheng YL, Hsieh CY, Wang CY, Chang YP, et al:
Anesthetic propofol reduces endotoxic inflammation by inhibiting
reactive oxygen species-regulated Akt/IKKβ/NF-κB signaling. PLoS
One. 6:e175982011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Vasileiou I, Xanthos T, Koudouna E, Perrea
D, Klonaris C, Katsargyris A and Papadimitriou L: Propofol: A
review of its non-anaesthetic effects. Eur J Pharmacol. 605:1–8.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu WZ and Liu N: Propofol inhibits lung
cancer A549 cells growth and epithelial-mesenchymal transition
process by up-regulation of microRNA-1284. Oncol Res. 27:1–8. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Du Q, Liu J, Zhang X, Zhang X, Zhu H, Wei
M and Wang S: Propofol inhibits proliferation, migration, and
invasion but promotes apoptosis by regulation of Sox4 in
endometrial cancer cells. Braz J Med Biol Res. 51:e68032018.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang LB, Feng L, He J, Liu B and Sun JG:
MiR-125a-5p inhibits the proliferation and invasion of breast
cancer cells and induces apoptosis by targeting GAB2. Math Biosci
Eng. 16:6923–6933. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cao Y, Shen T, Zhang C, Zhang QH and Zhang
ZQ: MiR-125a-5p inhibits EMT of ovarian cancer cells by regulating
TAZ/EGFR signaling pathway. Eur Rev Med Pharmacol Sci.
23:8249–8256. 2019.PubMed/NCBI
|
|
11
|
Zhang Z, Zhang S, Ma P, Jing Y, Peng H,
Gao WQ and Zhuang G: Lin28B promotes melanoma growth by mediating a
microRNA regulatory circuit. Carcinogenesis. 36:937–945. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yong W, Yu D, Jun Z, Yachen D, Weiwei W,
Midie X, Xingzhu J and Xiaohua W: Long noncoding RNA NEAT1,
regulated by LIN28B, promotes cell proliferation and migration
through sponging miR-506 in high-grade serous ovarian cancer. Cell
Death Dis. 9:8612018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhou J, Ng SB and Chng WJ: LIN28/LIN28B:
An emerging oncogenic driver in cancer stem cells. Int J Biochem
Cell Biol. 45:973–978. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Huang J, Cao D, Sha J, Zhu X and Han S:
DLL3 is regulated by LIN28B and miR-518d-5p and regulates cell
proliferation, migration and chemotherapy response in advanced
small cell lung cancer. Biochem Biophys Res Commun. 514:853–860.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang C, Gu Y, Zhang E, Zhang E, Zhang K,
Na Qin N, Dai J, Zhu M, Liu J, Xie K, et al: A cancer-testis
non-coding RNA LIN28B-AS1 activates driver gene LIN28B by
interacting with IGF2BP1 in lung adenocarcinoma. Oncogene.
38:1611–1624. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dong S, Wang R, Wang H, Ding Q, Zhou X,
Wang J, Zhang K, Long Y, Lu S, Hong T, et al: HOXD-AS1 promotes the
epithelial to mesenchymal transition of ovarian cancer cells by
regulating miR-186-5p and PIK3R3. J Exp Clin Cancer Res.
38:1102019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
R Core Team, . R: A language and
environment for statistical computing. R Foundation for Statistical
Computing, Vienna, 2014.
|
|
18
|
Vasaikar SV, Straub P, Wang J and Zhang B:
LinkedOmics: Analyzing multi-omics data within and across 32 cancer
types. Nucleic Acids Res. 46:D956–D963. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Agarwal V, Bell GW, Jin-Wu Nam JW and
Bartel DP: Predicting effective microRNA target sites in mammalian
mRNAs. Elife. 4:e050052015. View Article : Google Scholar
|
|
20
|
Chou CH, Shrestha S, Yang CD, Chang NW,
Lin YL, Liao KW, Huang WC, Sun TH, Tu SJ, Lee WH, et al: miRTarBase
update 2018: A resource for experimentally validated
microRNA-target interactions. Nucleic Acids Res. 46:D296–D302.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen Y and Wang X: miRDB: An online
database for prediction of functional microRNA targets. Nucleic
Acids Res. 48:D127–D131. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zou J, Li H, Huang Q, Liu X, Qi X, Wang Y,
Lu L and Liu Z: Dopamine-induced SULT1A3/4 promotes EMT and cancer
stemness in hepatocellular carcinoma. Tumour Biol.
39:10104283177192722017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang J, Zhang D, Wu GQ, Feng ZY and Zhu
SM: Propofol inhibits the adhesion of hepatocellular carcinoma
cells by upregulating microRNA-199a and downregulating MMP-9
expression. Hepatobiliary Pancreat Dis Int. 12:305–309. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ye Z, Jingzhong L, Yangbo L, Lei C and
Jiandong Y: Propofol inhibits proliferation and invasion of
osteosarcoma cells by regulation of microRNA-143 expression. Oncol
Res. 21:201–207. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wijnen JA and Rosenshein NB: Surgery in
ovarian cancer. Arch Surg. 115:863–868. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Park TW and Kuhn WC: Neoadjuvant
chemotherapy in ovarian cancer. Expert Rev Anticancer Ther.
4:639–647. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang Z, Zang M, Wang S and Wang C:
Effects of propofol on human cholangiocarcinoma and the associated
mechanisms. Exp Ther Med. 17:472–478. 2019.PubMed/NCBI
|
|
29
|
Wang J, Cheng CS, Lu Y, Ding X, Zhu M,
Miao C and Chen J: Novel findings of anti-cancer property of
propofol. Anticancer Agents Med Chem. 18:156–165. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Huang YH, Lee MS, Lou YS, Lai HC, Yu JC,
Lu CH, Wong CS and Wu ZF: Propofol-based total intravenous
anesthesia did not improve survival compared to desflurane
anesthesia in breast cancer surgery. PLoS One. 14:e02247282019.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sun Y, Peng YB, Ye LL, Ma LX, Zou MY and
Cheng ZG: Propofol inhibits proliferation and cisplatin resistance
in ovarian cancer cells through regulating the microRNA
374a/forkhead box O1 signaling axis. Mol Med Rep. 21:1471–1480.
2020.PubMed/NCBI
|
|
32
|
Song J, Shen Y, Zhang J and Lian Q: Mini
profile of potential anticancer properties of propofol. PLoS One.
9:e1144402014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Peng Z and Zhang Y: Propofol inhibits
proliferation and accelerates apoptosis of human gastric cancer
cells by regulation of microRNA-451 and MMP-2 expression. Genet Mol
Res. 15:152016. View Article : Google Scholar
|
|
34
|
Sun H and Gao D: Propofol suppresses
growth, migration and invasion of A549 cells by down-regulation of
miR-372. BMC Cancer. 18:12522018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang W, Wang Y, Zhu Z, Zheng Y and Song
B: Propofol inhibits proliferation, migration and invasion of
gastric cancer cells by up-regulating microRNA-195. Int J Biol
Macromol. 120:975–984. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yang N, Liang Y, Yang P, Yang T and Jiang
L: Propofol inhibits lung cancer cell viability and induces cell
apoptosis by upregulating microRNA-486 expression. Braz J Med Biol
Res. 50:e57942017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Huang X, Teng Y, Yang H and Ma J: Propofol
inhibits invasion and growth of ovarian cancer cells via regulating
miR-9/NF-κB signal. Braz J Med Biol Res. 49:e57172016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
McManus MT: MicroRNAs and cancer. Semin
Cancer Biol. 13:253–258. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wu L and Belasco JG: Micro-RNA regulation
of the mammalian lin-28 gene during neuronal differentiation of
embryonal carcinoma cells. Mol Cell Biol. 25:9198–9208. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wu ZF, Lee MS, Wong CS, Lu CH, Huang YS,
Lin KT, Lou YS, Lin C, Chang YC and Lai HC: Propofol-based total
intravenous anesthesia is associated with better survival than
desflurane anesthesia in colon cancer surgery. Anesthesiology.
129:932–941. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ikeda T, Kurasako N, Nishitani K, Okada S
and Arai T: Anesthetic management for removal of a giant ovarian
tumor using FloTrac X Vigileo monitoring system. Masui. 63:439–442.
2014.(In Japanese). PubMed/NCBI
|
